Skip to content

Evolus EOLS Total Cost of Revenue

Total Cost of Revenue at other companies

AbbVie logo
AbbVieABBV
$4.22B+5.4%

Segments

By segment

See full
Reportable Segment$24.24M+10.9%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's total cost of revenue?
Evolus (EOLS) reported total cost of revenue of $24.24M in Q1 2026.
How has Evolus's total cost of revenue changed year-over-year?
Evolus's total cost of revenue increased by 10.9% year-over-year, from $21.87M to $24.24M.
What is the long-term trend for Evolus's total cost of revenue?
Over 4 years (2021 to 2025), Evolus's total cost of revenue has grown at a 23.1% compound annual growth rate (CAGR), from $43.53M to $100.07M.
What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.